Economy

Analyst Stock Ratings: Boston Scientific Corporation (BSX), Northern Trust Corporation (NTRS)

First Republic Investment Management Inc. now owns 294,625 shares of the company's stock worth $5,541,000 after buying an additional 122,466 shares during the last quarter.

An earnings forecast is an analyst's outlook for a company's future quarterly or annual earnings. BSX generated revenue of $2.31 Billion in the same quarter, one year ago. The company has a current ratio of 0.72, a quick ratio of 0.50 and a debt-to-equity ratio of 0.58. About 2.17 million shares traded.

Kevin Michael Ulrich decreased its stake in Boston Scientific Corp (BSX) by 6.91% based on its latest 2017Q2 regulatory filing with the SEC. Wells Fargo & Company MN now owns 9,157,768 shares of the medical equipment provider's stock valued at $253,854,000 after buying an additional 867,983 shares during the last quarter. Its down 1.15% from 147,600 shares previously. Gateway Investment Advisers LLC boosted its position in shares of Boston Scientific Corporation by 8.4% during the 2nd quarter. The stock rose 0.40% or $0.11 reaching $27.92.

About 2.11 million shares traded or 141.28% up from the average. According to today's trading volume Boston Scientific Corporation is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days. Stifel owns 1.32M shares or 0.14% of their USA portfolio. Catawba Cap Mgmt Va owns 32,505 shares or 0.21% of their United States portfolio. Iguana Management Limited Liability Com accumulated 0.86% or 55,000 shares. Nfc Invests Limited invested in 1.98% or 236,160 shares. There has been an observed change of -34.36% in the ownership of the shares in the past six months. Parthenon Ltd Co owns 13,133 shares. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase (PI3K) enzymes. Gradient Invs Lc holds 0% or 9 shares. Principal Finance Gru owns 15,153 shares for 0% of their portfolio. United Asset Strategies Inc. owns 105,622 shares or 0.79% of their U.S. portfolio. A statistical measure of the dispersion of returns (volatility) for BSX producing salvation in Investors mouth, it has week volatility of 1.88% and for the month booked as 1.42%.

Since May 17, 2017, it had 0 insider buys, and 5 sales for $1.91 million activity. Winter Matthew E had sold 48,058 shares worth $4.27M on Thursday, June 15. Afam Capital stated it has 0.29% of its portfolio in Allstate Corp (NYSE:ALL).

Investors sentiment increased to 1.03 in 2017 Q2. Its down 0.18, from 0.94 in 2017Q1. It increased, as 41 investors sold BSX shares while 173 reduced holdings. 68 funds opened positions while 213 raised stakes. Wcm Invest Mngmt Ca owns 2.27M shares for 0.97% of their portfolio.

Many analysts are providing their Estimated Earnings analysis for Boston Scientific Corporation and for the current quarter 24 analysts have projected that the stock could give an Average Earnings estimate of $0.34/share. Finally, Oppenheimer Holdings, Inc. restated a "hold" rating on shares of Boston Scientific Corporation in a research note on Wednesday, August 9th.

Boston Scientific Corporation (NYSE:BSX) last issued its quarterly earnings data on Thursday, October 26th. Crestwood Advsrs Grp Inc Limited Liability Corp holds 21,847 shares. The original version of this report can be accessed at https://weekherald.com/2017/11/07/boston-scientific-corporation-bsx-shares-bought-by-prudential-financial-inc.html. 47,167 were reported by Capital Fincl Advisers Ltd Liability Company.

In other Boston Scientific Corporation news, EVP Timothy A. Pratt sold 10,104 shares of the firm's stock in a transaction on Friday, September 1st. The Connecticut-based Cubist Systematic Strategies has invested 0.09% in Boston Scientific Corporation (NYSE:BSX). Focused Wealth Mgmt Inc invested in 100 shares.

Analysts believe that the company has the potential to earn average revenue of $2.35 Billion for the current quarter. Therefore 79% are positive. The stock has "Strong Buy" rating by Raymond James on Monday, October 5. Royal Bank Of Canada reiterated a "buy" rating and issued a $31.00 price objective on shares of Boston Scientific Corporation in a report on Wednesday, July 12th. The company was maintained on Thursday, October 29 by FinnCap. Needham & Company LLC increased their price target on Boston Scientific Corp. from $26.00 to $28.00 and gave the company a "buy" rating in a research note on Friday, July 29th.



Like this

loading...
loading...

Latest


07 November 2017
UBS Asset Management Americas Inc. Cuts Holdings in Pacira Pharmaceuticals, Inc. (PCRX)
It dropped, as 67 investors sold CTL shares while 185 reduced holdings. 123 funds opened positions while 564 raised stakes. Cowen and Company restated a "hold" rating on shares of Pacira Pharmaceuticals in a report on Tuesday, September 20th.

07 November 2017
Google Assistant comes to Sony TVs
Sony bears no responsibility in the event that services offered by third parties are changed, disrupted, suspended or terminated. Starting today, Google Assistant on Android and iOS will be able to send you daily weather updates, quotes, and more.

07 November 2017
Stop Giving Your Animals So Many Antibiotics — WHO To Farmers
Antibiotics that are considered to be in the last line of defence for humans should not be used at all it says. But it's hard to know how to allow therapy while still avoiding inappropriate use, Drekonja said.

07 November 2017
Trump administration to allow states to impose work requirements on Medicaid recipients
About 59 percent of nondisabled adults on Medicaid who are under 65 years old have jobs, the organization found. Verma suggested work requirements were an appropriate response to the expanded Medicaid population.

07 November 2017
Gilead Sciences, Inc. (NASDAQ:GILD) Underpriced by 14.3%?
Jefferies maintained the shares of CASY in report on Thursday, August 31 with "Buy" rating. (NASDAQ:GILD) on Thursday, June 1. Pacad Investment Ltd. lifted its stake in shares of Gilead Sciences by 122.1% in the 2nd quarter. (NYSE:BLK) or 5,745 shares.

07 November 2017
Strs Ohio Grows Position in Viacom Inc. (VIAB)
Viacom, Inc . (NASDAQ: VIAB ) touched its 1-Year High price of $46.72 on 03/31/17 and its 1-Year Low price of $22.88 on 11/03/17. Strs Ohio owned about 0.08% of Viacom worth $8,478,000 as of its most recent filing with the Securities & Exchange Commission.

07 November 2017
Pain relievers worked as well as opioids in ER patients
Chang and his colleagues looked at two urban emergency departments from July 2015 to August 2016. Results were published Tuesday in the Journal of the American Medical Association .

07 November 2017
Comparable Company Analysis: STORE Capital Corporation (STOR), Sinclair Broadcast Group, Inc. (SBGI)
The stock of Sinclair Broadcast Group Inc (NASDAQ: SBGI ) has "Buy" rating given on Wednesday, November 1 by RBC Capital Markets. Lucas now expects that the company will post earnings of $1.91 per share for the year, down from their prior estimate of $2.04.

07 November 2017
Global Gas Tank Container Market 2017- Hitachi, FURUISE , Uralcryomash, Corban Energy Group
This report additionally presents product specification, producing method, and products cost structure. High Use of Gas Tank Container in Machines Industry Driving the Market Growth of Gas Tank Container.

07 November 2017
Hard Facts About Envision Healthcare Holdings, Inc. (NYSE:EVHC)
Reinhart Partners Inc. owned 0.52% of Envision Healthcare Corporation worth $28,126,000 at the end of the most recent quarter. Schwab Charles Investment Management Inc. raised its position in Envision Healthcare Corporation by 5.6% in the 2nd quarter.